NL
DE
8 April 2020
The anDREa consortium developed a test version of an app which gives the opportunity to start or close a Virtual Machine from a mobile device. One of the advantages is that it gives you the possibility to start a VM before you actually start working in the DRE which will decrease the time you have to spend on waiting till the VM is up.
This app is available in a beta version. We are looking for 3 testers to verify whether the functionality of the app adds value to your work. If you would like to participate in testing the app, please send an email to Karin Stukker, project lead Implementation DRE.
The anDREa consortium developed a test version of an app which gives the opportunity to start or close a Virtual Machine from a mobile device. One of the advantages is that it gives you the possibility to start a VM before you actually start working in the DRE which will decrease the time you have to spend on waiting till the VM is up.
This app is available in a beta version. We are looking for 3 testers to verify whether the functionality of the app adds value to your work. If you would like to participate in testing the app, please send an email to Karin Stukker, project lead Implementation DRE.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
LUMO Labs and Oost NL invest in Aiosyn Investment accelerates development of artificial intelligence platform to improve diagnostics
7 February 2022 Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor. read more
Dutch-Nordic Alliance for Precision Cancer Medicine launched
26 November 2021 The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands. read more
Large AI project receives over €95 million for ten years of public-private research
23 September 2021 The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs. read moreNew start-up Patholyt will bring AI research into pathology diagnostics
21 September 2021 Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research. read moreNijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview
22 July 2021 Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map. read more
